Noninvasive tests for liver fibrosis in 2024:are there different scales for different diseases?Jimmy Che-To Lai，Lilian Yan Liang，Grace Lai-Hung Wong517-531
Preoperative risk evaluation and optimization for patients with liver diseaseSameer Bhalla，Brendan Mcquillen，Edward Cay，Nancy Reau532-543
Postpartum hepatitis flares in mothers with chronic hepatitis B infectionShi OuYang，Yawen Geng，Gongqin Qiu，Yueying Deng，Haitao Deng，Calvin Q.Pan556-567
New perspectives in hepatocellular carcinoma surveillance after hepatitis C virus eradicationCalvin Q.Pan，Andrew J.Park，James S.Park568-574
Active role of the immune system in metabolic dysfunction-associated steatotic liver diseaseTaizo Mori，Sachiyo Yoshio，Eiji Kakazu，Tatsuya Kanto575-585
Advances in the management of alcohol-associated liver diseaseAhmad Anouti，Thomas A.Kerr，Mack C.Mitchell，Thomas G.Cotter586-601
Independent and additive effects of binge drinking and obesity on liver enzymes:a cross-sectional analysis using the Korean National Health Insurance Service dataAnthony Kityo，Sang-Ah Lee602-609
Association between low-normal thyroid function and advanced liver fibrosis in metabolic dysfunction-associated fatty liver disease patients:a retrospective cohort studyZixuan Li，Xiaoying Wu，Zebin Chen，Xiuqing Wei，Weiqing Chen610-615
